Fabien B Vincent

Summary

Publications

  1. doi request reprint Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
    Fabien B Vincent
    B lymphocyte, BAFF and Autoimmunity Laboratory, Department of Immunology, Monash University, Level 2, AMREP Building, 89 Commercial Road, Melbourne, Victoria 3004, Australia
    Ann Rheum Dis 72:165-78. 2013
  2. doi request reprint BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus
    Fabien B Vincent
    Department of Immunology, Monash University, Central Clinical School, Alfred Medical Research and Education Precinct AMREP, Melbourne, Victoria, Australia
    Immunol Cell Biol 90:293-303. 2012
  3. ncbi request reprint The BAFF/APRIL system in SLE pathogenesis
    Fabien B Vincent
    Department of Immunology, Monash University, Central Clinical School, Alfred Medical Research and Education Precinct AMREP, 89 Commercial Road, Melbourne, VIC 3004, Australia
    Nat Rev Rheumatol 10:365-73. 2014

Detail Information

Publications4

  1. doi request reprint Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
    Fabien B Vincent
    B lymphocyte, BAFF and Autoimmunity Laboratory, Department of Immunology, Monash University, Level 2, AMREP Building, 89 Commercial Road, Melbourne, Victoria 3004, Australia
    Ann Rheum Dis 72:165-78. 2013
    ..Such an approach could improve chronic inflammatory disease management toward a personalized and more cost-effective approach...
  2. doi request reprint BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus
    Fabien B Vincent
    Department of Immunology, Monash University, Central Clinical School, Alfred Medical Research and Education Precinct AMREP, Melbourne, Victoria, Australia
    Immunol Cell Biol 90:293-303. 2012
    ..We will also review promising therapies presently in clinical trials targeting innate immunity, which are likely to revolutionize SLE management towards a personalized and targeted therapy approach...
  3. ncbi request reprint The BAFF/APRIL system in SLE pathogenesis
    Fabien B Vincent
    Department of Immunology, Monash University, Central Clinical School, Alfred Medical Research and Education Precinct AMREP, 89 Commercial Road, Melbourne, VIC 3004, Australia
    Nat Rev Rheumatol 10:365-73. 2014
    ..The role of a related cytokine, TNF ligand superfamily member 13 (also known as a proliferation-inducing ligand [APRIL]) in SLE is much less well understood, and hence this review focuses on BAFF. ..